Betamek Berhad First Quarter 2026 Earnings: EPS: RM0.012 (vs RM0.011 in 1Q 2025)
Key Financial Results
Revenue: RM56.9m (up 14% from 1Q 2025).
Net income: RM5.39m (up 11% from 1Q 2025).
Profit margin: 9.5% (in line with 1Q 2025).
EPS: RM0.012 (up from RM0.011 in 1Q 2025).
AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.
All figures shown in the chart above are for the trailing 12 month (TTM) period
Betamek Berhad shares are up 5.1% from a week ago.
Risk Analysis
You still need to take note of risks, for example - Betamek Berhad has 3 warning signs we think you should be aware of.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
19 minutes ago
- Yahoo
Sana Biotechnology Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
SEATTLE, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (Nasdaq: SANA) ('Sana'), a company focused on changing the possible for patients through engineered cells, today announced that it has commenced an underwritten public offering of $75.0 million of shares of its common stock and, in lieu of common stock to certain investors, pre-funded warrants to purchase shares of its common stock. In addition, Sana intends to grant the underwriters a 30-day option to purchase up to an additional $11.25 million of shares of its common stock. All of the shares of common stock and pre-funded warrants to be sold in the proposed offering will be sold by Sana. The proposed offering is subject to market and other conditions, and there can be no assurance as to whether or when the proposed offering may be completed, or as to the actual size or terms of the proposed offering. Morgan Stanley, Goldman Sachs & Co. LLC, BofA Securities, and TD Cowen are acting as joint book-running managers for the proposed offering. The proposed offering is being made pursuant to a Registration Statement on Form S-3, including a base prospectus, previously filed with and declared effective by the SEC, and Sana will file a preliminary prospectus supplement and accompanying prospectus relating to and describing the terms of the proposed offering, copies of which can be accessed for free through the SEC's website at When available, copies of the preliminary prospectus supplement and the accompanying prospectus relating to the proposed offering may also be obtained from: Morgan Stanley & Co. LLC, Attention: Prospectus Department, 180 Varick Street, 2nd Floor, New York, NY 10014 or by email at prospectus@ Goldman Sachs & Co. LLC, Attn: Prospectus Department, at 200 West Street, New York, NY 10282, by telephone at (866) 471-2526 or by email at prospectus-ny@ BofA Securities, Attn: Prospectus Department, NC1-022-02-25, 201 North Tryon Street, Charlotte, NC 28255-0001 or by email at or TD Securities (USA) LLC, 1 Vanderbilt Avenue, New York, New York 10017, by telephone at (855) 495-9846 or by email at This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor will there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation, or sale would be unlawful before registration or qualification under the securities laws of any such state or jurisdiction. About Sana Biotechnology Sana Biotechnology, Inc. is focused on creating and delivering engineered cells as medicines for patients. Sana has operations in Seattle, WA, Cambridge, MA, and South San Francisco, CA. Cautionary Note Regarding Forward-Looking Statements This press release contains forward-looking statements about Sana Biotechnology, Inc. (the 'Company,' 'we,' 'us,' or 'our') within the meaning of the federal securities laws, including those related to the completion, timing, and size of the proposed offering and our intent to grant the underwriters a 30-day option to purchase additional shares. These forward-looking statements are neither promises nor guarantees and are subject to a variety of risks and uncertainties, including but not limited to: whether or not we will be able to raise capital through the sale of securities or consummate the offering; the final terms of the offering; the satisfaction of customary closing conditions; prevailing market conditions; general economic and market conditions as well as geopolitical developments; and other risks. Information regarding the foregoing and additional risks may be found in the section entitled 'Risk Factors' in documents that we file from time to time with the Securities and Exchange Commission, including the registration statement and the preliminary prospectus supplement relating to the proposed public offering. These forward-looking statements are made as of the date of this press release, and we assume no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Investor Relations & Media: Nicole in to access your portfolio
Yahoo
19 minutes ago
- Yahoo
Informa TechTarget to Announce Q2 2025 Financial Results on August 12, 2025
Live Conference Call and Webcast Scheduled to Begin at 8:30 a.m. ET on August 12, 2025 NEWTON, Mass., August 06, 2025--(BUSINESS WIRE)--TechTarget, Inc. (Nasdaq: TTGT) ("Informa TechTarget" or the "Company"), a leading growth accelerator for the B2B Technology sector, today announced that it will release its Q2 2025 financial results for the three months ended June 30, 2025 before the market opens on Tuesday, August 12, 2025. The Company's Chief Executive Officer, Gary Nugent, and Chief Financial Officer, Dan Noreck, will host a live conference call and webcast at 8:30 a.m. Eastern Time on that day to discuss the Company's financial results and outlook. The Q2 2025 financial results will be available prior to the conference call and webcast on the investor relations section of the Company's website at Conference Call Dial-In Information: United States (Toll Free): 1-833-470-1428 United States: 1-404-975-4839 United Kingdom (Toll Free): +44 808 189 6484 United Kingdom: +44 20 8068 2558 Global Dial-in Numbers Access code: 967110 Please access the call at least 10 minutes prior to the time the conference is set to begin. Please ask to be joined into the Informa TechTarget call. Conference Call Webcast Information: This webcast can be accessed via Informa TechTarget's website at Conference Call Replay Information: A replay of the conference call will be available via telephone beginning one (1) hour after the conference call through September 11, 2025 at 11:59 p.m. ET. To hear the replay: United States (Toll Free): 1-866-813-9403 United States: 1-929-458-6194 Access Code: 703085 A web version will also be available for replay during the same period on Informa TechTarget's website at About Informa TechTarget TechTarget, Inc. (Nasdaq: TTGT), which also refers to itself as Informa TechTarget, informs, influences and connects the world's technology buyers and sellers, helping accelerate growth from R&D to ROI. With a vast reach of over 220 highly targeted technology-specific websites and over 50 million permissioned first-party audience members, Informa TechTarget has a unique understanding of and insight into the technology market. Underpinned by those audiences and their data, we offer expert-led, data-driven, and digitally enabled services that have the potential to deliver significant impact and measurable outcomes to our clients: Trusted information that shapes the industry and informs investment Intelligence and advice that guides and influences strategy Advertising that grows reputation and establishes thought leadership Custom content that engages and prompts action Intent and demand generation that more precisely targets and converts Informa TechTarget is headquartered in Boston, MA and has offices in 19 global locations. For more information, visit and follow us on LinkedIn. © 2025 TechTarget, Inc. All rights reserved. All trademarks are the property of their respective owners. View source version on Contacts Investor Inquiries Daniel NoreckMitesh KotechaInforma TechTarget617-431-9200investor@ Media Inquiries Garrett MannCorporate CommunicationsInforma
Yahoo
19 minutes ago
- Yahoo
Horace Mann reports second-quarter 2025 results
SPRINGFIELD, Ill., August 06, 2025--(BUSINESS WIRE)--Horace Mann Educators Corporation (NYSE:HMN), the largest multiline financial services company focused on helping America's educators and a core small-cap growth and value equity in the Financials sector, today reported financial results for the three and six months ended June 30, 2025: Diversified business delivered second-quarter net income of $29.4 million, or $0.71 per share, and record core earnings* of $44.2 million, or $1.06 per share, with reported book value of $33.31 and adjusted book value* of $38.46 at quarter end Total revenue rose 6% for the quarter, with net premiums and contract charges earned up 8% Second-quarter Property & Casualty segment combined ratio of 97.0% improved 15 points over prior year Full-year 2025 core EPS guidance increased to $4.15 to $4.45, with a double-digit shareholder return on equity ($ in millions, except per share amounts) Three Months Ended June 30, Six Months Ended June 30, 2025 2024 % Change 2025 2024 % Change Total revenues $ 411.7 $ 388.1 6.1 % $ 828.1 $ 774.1 7.0 % Net income 29.4 3.8 673.7 % 67.6 30.3 123.1 % Net investment gains (losses), after tax (4.7 ) (4.6 ) N.M. (7.3 ) (2.9 ) N.M. Non-core earnings, after tax* (10.1 ) (2.9 ) N.M. (14.0 ) (3.9 ) N.M. Core earnings* 44.2 11.3 291.2 % 88.9 37.1 139.6 % Per diluted share: Net income 0.71 0.09 688.9 % 1.63 0.73 123.3 % Net investment gains (losses), after tax (0.11 ) (0.11 ) N.M. (0.17 ) (0.07 ) N.M. Non-core earnings, after tax* (0.24 ) (0.07 ) N.M. (0.34 ) (0.09 ) N.M. Core earnings per diluted share* 1.06 0.27 292.6 % 2.14 0.89 140.4 % Book value per share 33.31 29.60 12.5 % Adjusted book value per share* 38.46 36.33 5.9 % Tangible book value per share* 33.46 31.01 7.9 % Core ROE - LTM* 12.6 % 6.5 % 6.1 pts N.M. - Not meaningful. * These measures are not based on accounting principles generally accepted in the United States of America (non-GAAP). They are reconciled to the most directly comparable GAAP measures in the Appendix to the Investor Supplement. An explanation of these measures is contained in the Glossary of Selected Terms included as an exhibit in the Company's reports filed with the Securities and Exchange Commission. Included in the second quarter non-core earnings, in addition to recurring adjustments defined in Exhibit 99.1, is an infrequent item that is not indicative of on-going operations, the Company recorded an ($8.1) million adjustment to net investment income due to an immaterial out-of-period correction related to private debt securities associated with the Company's limited partnership investments. See additional disclosure contained in Note 1 of the June 30, 2025 Form 10-Q. "Record second-quarter core earnings reflect very strong business profitability and solid growth momentum, as well as Property & Casualty catastrophe costs that were meaningfully below prior year and recent prior periods," said Horace Mann President & CEO Marita Zuraitis. "Taking first-half results into consideration, we are increasing our full-year 2025 core EPS guidance to a range of $4.15 to $4.45. We continue to execute on our strategy to drive sustained, profitable growth, and we are on track to meet our 2025 annual goals of record core earnings and a double-digit shareholder return on equity. "Our results clearly illustrate Horace Mann's ability to empower all educators to achieve lifelong financial success, while also helping employers attract and retain employees by providing more comprehensive benefits," Zuraitis added. "The diversification of our business reflects our strategy to deliver consistent and reliable value to shareholders with a solid balance sheet and a compelling dividend." Simultaneous with this release, the Quarterly Results page of has been updated to include the second-quarter Quarterly Report on Form 10-Q, investor supplement and investor presentation. These include details on company and segment financial performance, company guidance and outlook. Quarterly webcast Horace Mann's senior management will discuss the company's second-quarter financial results with investors on August 7, 2025 at 11 am Eastern Time. The conference call will be webcast live at and available later in the day for replay. About Horace Mann Horace Mann Educators Corporation (NYSE: HMN) is the largest multiline financial services company focused on helping America's educators and others who serve the community achieve lifelong financial success. The company offers individual and group insurance and financial solutions tailored to the needs of the educational community. Founded by Educators for Educators® in 1945, Horace Mann is headquartered in Springfield, Illinois. For more information, visit Safe Harbor Statement and Non-GAAP Measures Certain statements included in this news release, including those regarding our earnings outlook, expected catastrophe losses, our investment strategies, our plans to implement additional rate actions, our plans relating to share repurchases and dividends, our efforts to enhance customer experience and expand our products and solutions to more educators, our strategies to create sustainable long-term growth and double-digit ROEs, our strategy to achieve a larger share of the education market, and other business strategies, constitute forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements are made based on management's current expectations and beliefs concerning future developments and their potential effects upon Horace Mann and its subsidiaries. Horace Mann cautions investors that such statements are subject to risks and uncertainties, many of which are difficult to predict and generally beyond Horace Mann's control, that could cause actual results to differ materially from those expressed in, or implied or projected by, the forward-looking statements included in this document. Certain important factors that could cause actual results to differ, possibly materially, from expectations or estimates reflected in such forward-looking statements can be found in the "Risk Factors" and "Forward-Looking Information" sections included in Horace Mann's Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q filed with the Securities and Exchange Commission (SEC). The forward-looking statements herein are subject to the risk, among others, that we will be unable to execute our strategy because of market or competitive conditions or other factors. Horace Mann does not undertake to update any particular forward-looking statement included in this document if we later become aware that such statement is not likely to be achieved. Information contained in this news release include measures which are based on methodologies other than accounting principles generally accepted in the United States of America (GAAP). Reconciliations of non-GAAP measures to the closest GAAP measures are contained in the Appendix to the Investor Supplement and additional descriptions of the non-GAAP measures are contained in the Glossary of Selected Terms included as an exhibit to Horace Mann's SEC filings. View source version on Contacts Brendan Dawal, Vice President, Investor Relations217-670-8766 | investorrelations@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
